Tat-indoleamine 2,3-dioxygenase 1 elicits neuroprotective effects on ischemic injury

키워드

참고문헌 (49)

1. Tas SW, "Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2, 3-dioxygenase(IDO)induction and immune regulation", Blood, 1, pp.1540~1549 (2007)
2. Uyttenhove C, "Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2, 3-dioxygenase", Nat Med, 9, pp.1269~1274 (2003)
3. Wang XF, "The role of indoleamine 2, 3-dioxygenase(IDO)in immune tolerance : focus on macrophage polarization of THP-1 cells", Cell Immunol, 289, pp.42~48 (2014)
4. Hirata F, "Intracellular utilization of superoxide anion by indoleamine 2, 3-dioxygenase of rabbit enterocytes", J Biol Chem, 252, pp.2774~1776 (1977)
5. Chen Y, "Kynurenine pathway metabolites in humans : Disease and healthy states", Int J Tryptophan Res, 2, pp.1~19 (2009)
6. Lugo-Huitron R, "On the antioxidant properties of kynurenic acid : free radical scavenging activity and inhibition of oxidative stress", Neurotoxicol Teratol, 33, pp.538~547 (2011)
7. Takikawa O, "Biochemical and medical aspects of the indoleamine 2, 3-dioxygenase-initiated L-tryptophan metabolism", Biochem Biophys Res Commun, 338, pp.12~19 (2005)
8. Liu H, "Nonviral gene delivery with indoleamine 2, 3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury", Am J Transplant, 10, pp.2291~2300 (2007)
9. Yun TJ, "Indoleamine 2, 3-dioxygenase-expressing aortic plasmacytoid dendritic cells protect against atherosclerosis by induction of regulatory T cells", Cell Metab, 23, pp.852~866 (2016)
10. Chen X, "Oxidative stress in neurodegenerative diseases", Neural Regen Res, 7, pp.376~385 (2012)
11. 김건하, "The Role of Oxidative Stress in Neurodegenerative Diseases", Experimental Neurobiology, 24(4), pp.325~340 (2015), 한국뇌신경과학회
12. Ashafaq M, "Catechin hydrate ameliorates redox imbalance and limits inflammatory response in focal cerebral ischemia", Neurochem Res, 37, pp.1747~1760 (2012)
13. Lei C, "Reactive oxygen species scavenger inhibits STAT3 activation after transient focal cerebral ischemia-reperfusion injury in rats", Anesth Analg, 113, pp.153~159 (2011)
14. Jeong HJ, "Neuroprotective effect of PEP-1-peroxiredoxin2 on CA1 regions in the hippocampus against ischemic insult", Biochim Biophys Acta, 1840, pp.2321~2330 (2014)
15. Kim SM, "Tat-antioxidant 1protects against stress-induced hippocampal TH-22 cell death and ischemic insult in animal model", J Cell Mol Med, 19, pp.1333~1345 (2015)
16. Cheng J, "The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking", mitochondrial dysfunction, MAPK pathway in neurons, pp.Eur J Pharmacol, 2011[DOI]
17. Dhanasekaran DN, "JNK signaling in apoptosis", Oncogene, 27, pp.6245~6251 (2008)
18. Kim SD, "Identification of ASK1, MKK4, JNK, c-Jun, and caspase-3as a signaling cascade involved in cadmium-induced neuronal cell apoptosis", Biochem Biophys Res Commun, 328, pp.326~334 (2005)
19. Ouyang M, "Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells", J Neurochem, 97, pp.234~244 (2006)
20. Wadia JS, "Protein transduction technology", Curr Opin Biotechnol, 13, pp.52~56 (2002)
21. Cerrato CP, "Novel cell-penetrating peptide targeting mitochondria", FASEB J, 29, pp.4589~4599 (2015)
22. Jo HS, "Tat-DJ-1 enhances cell survival by inhibition of oxidative stress, NF-B and MAPK activation in HepG2 cells", Biotechnol Lett, 39, pp.511~521 (2017)
23. Kim MJ, "Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson’s disease model", Biomaterials, 64, pp.45~56 (2015)
24. Gellert L, "Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia", Eur J Pharmacol, 667, pp.182~187 (2011)
25. Lovelace MD, "Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases", Neuropharmacol, 112, pp.373~388 (2017)
26. Duleu S, "Circulating antibodies to IDO", THO pathway metabolites in Alzheimer’s disease, 2010, pp.2010, 6~
27. Hu P, "Increased indoleamine 2, 3-dioxygenase and quinolinic acid expression in microglia and muller cells of diabetic human and rodent retina", Invest Ophthalmol Vis Sci, 58, pp.5043~5055 (2017)
28. Taniguchi T, "Indoleamine 2, 3-dioxygenase. Kinetic studies on the binding of superoxide anion and molecular oxygen to enzyme", J Biol Chem, 254, pp.3288~3294 (1979)
29. Sun Y, "Indoleamine 2, 3-dioxygenase-a new antioxidant enzyme", Mater Med Pol, 21, pp.244~250 (1989)
30. Freewan M, "Human indoleamine 2, 3-dioxygenase is a catalyst of physiological heme peroxidase reactions : implications for the inhibition of dioxygenase activity by hydrogen peroxide", J Biol Chem, 288, pp.1548~1567 (2013)
31. Ramsey JD, "Cell-penetrating peptides transport therapeutics into cells", Pharmacol Ther, 54, pp.78~86 (2015)
32. 문정일, "Enhanced delivery of protein fused to cell penetrating peptides to mammalian cells", BMB Reports, 52(5), pp.324~329 (2019), 생화학분자생물학회[DOI]
33. Zhang X, "Tat PTD-endostatin : A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops", Biochim Biophys Acta, 1850, pp.1140~1149 (2015)
34. Shin MJ, "Tat-glyoxalase protein inhibits against ischemic neuronal cell damage and ameliorates ischemic injury", Free Radic Biol Med, 67, pp.195~210 (2014)
35. Yeo HJ, "Tat-CIAPIN1 inhibits hippocampal neuronal cell damage through the MAPK and apoptotic signaling pathways", Free Radic Biol Med, 135, pp.68~78 (2019)
36. Nakashima M, "Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat", Free Radic Biol Med, 26, pp.722~729 (1999)
37. Taguchi A, "Localization and spatiotemporal expression of IDO following transient forebrain ischemia in gerbils", Brain Res, 1217, pp.78~85 (2008)
38. Liang K, "Formononetin mediates neuroprotection against cerebral ischemia", reperfusion in rats via downregulation of the Bax, Akt signaling pathway, pp.J Neurol Sci, 2014[DOI]
39. Zhang X, "Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3", J Biol Chem, 278, pp.1248~1258 (2002)
40. Ferrer I, "Bcl-2, Bax, and Bcl-x expression in the CA1 area of the hippocampus following transient forebrain ischemia in the adult gerbil", Exp Brain Res, 121, pp.167~173 (1998)
41. Zhu N, "Schisandrin B prevents hind limb from ischemiareperfusion-induced oxidative stress and inflammation via MAPK", NF-kappaB pathways in Rats, 2017, pp.2017, 4237973~
42. Kwon SH, "The neuroprotective effects of Lonicera japonica THUNB. against hydrogen peroxide-induced apoptosis via phosphorylation of MAPKs and PI3K", Akt in SH-SY5Y cells, 2011, pp.49, 1011~1019
43. Jia L, "MAPK pathway mediates the anti-oxidative effect of chicoric acid against cerebral ischemia-reperfusion injury in vivo", Exp Ther Med, 15, pp.1640~1646 (2018)
44. Guillemin GJ, "Expression of indoleamine 2, 3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons", Glia, 49, pp.15~23 (2005)
45. Grant RS, "IDO induction in IFN-gamma activated astroglia : a role in improving cell viability during oxidative stress", Redox Rep, 5, pp.101~104 (2000)
46. Sugawara T, "Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats", J Neurotrauma, 19, pp.85~98 (2002)
47. Chu K, "Inhibition of P2X7receptor ameliorates transient global cerebral ischemia", reperfusion injury via modulating inflammatory responses in the rat hippocampus, 2012, pp.9, 69~
48. Morizawa YM, "Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway", Nat Commun, 8, pp.28~ (2017)
49. Annunziato L, "Ionic transporter activity in astrocytes, microglia, and oligodendrocytes during brain ischemia", J Cereb Blood Flow Metab, 33, pp.969~982 (2013)

관련 논문AI추천